Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352)

Clinical trial NCT00202865 · COMPLETED

Trial details

NCT number: NCT00202865
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Spondylitis, Ankylosing

Start date: 2005-05-01
Primary completion: 2007-05-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.